A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Public ClinicalTrials.gov record NCT05147233. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle in the Treatment of Inflammation and Pain Following Cataract Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a randomized, double-masked, vehicle-controlled, Phase 3 study evaluating the efficacy and safety of OCS-01 QD compared to vehicle in the treatment of inflammation and pain following cataract surgery.
Study identification
- NCT ID
- NCT05147233
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 241 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 24, 2022 (Actual)
- Primary completion
- Jun 22, 2023 (Actual)
- Completion
- Jul 3, 2023 (Actual)
- Last update posted
- Jul 11, 2025
2022 – 2023
United States locations
- U.S. sites
- 25
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Oculis Site 16 | Chandler | Arizona | 85224 | — |
| Oculis Site 28 | Phoenix | Arizona | 85003 | — |
| Oculis Site 8 | Fayetteville | Arkansas | 72704 | — |
| Oculis Site 9 | Inglewood | California | 90301 | — |
| Oculis Site 23 | Newport Beach | California | 92663 | — |
| Oculis Site 26 | Petaluma | California | 94954 | — |
| Oculis Site 24 | San Pedro | California | 90731 | — |
| Oculis Site 22 | Westminster | California | 92683 | — |
| Oculis Site 11 | Fort Collins | Colorado | 80528 | — |
| Oculis Site 12 | Tamarac | Florida | 33321 | — |
| Oculis Site 17 | Morrow | Georgia | 30260 | — |
| Oculis Site 20 | Louisville | Kentucky | 40206 | — |
| Oculis Site 5 | St Louis | Missouri | 63128 | — |
| Oculis Site 3 | Washington | Missouri | 63090 | — |
| Oculis Site 13 | Kinston | North Carolina | 28501 | — |
| Oculis Site 6 | Brecksville | Ohio | 44141 | — |
| Oculis Site 14 | Cincinnati | Ohio | 45242 | — |
| Oculis Site 25 | Eugene | Oregon | 97401 | — |
| Oculis Site 7 | Kingston | Pennsylvania | 18704 | — |
| Oculis Site 4 | Austin | Texas | 78731 | — |
| Oculis Site 10 | Houston | Texas | 77025 | — |
| Oculis Site 2 | San Antonio | Texas | 78229 | — |
| Oculis Site 31 | San Antonio | Texas | 78229 | — |
| Oculis Site 27 | Salt Lake City | Utah | 84032 | — |
| Oculis Site 30 | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05147233, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 11, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05147233 live on ClinicalTrials.gov.